Finch Therapeutics Group Inc. (FNCH)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 683 |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q2 2023 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 0.01% | 4 | 0.00 | |
| Q1 2023 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 98.13% | 33,333 | 0.00 | |
| Q4 2022 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 9.27% | 3,470 | 0.00 | |
| Q1 2022 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 0.81% | 305 | 0.00 | |
| Q4 2021 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 6.28% | 2,531 | 0.01 | |
| Q1 2021 | |||||
| ≡ | Seth Klarman - Baupost Group | Buy | 40,271 | 0.15 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.